Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Clinical Trials Insight: 700020249

Trial Profile

Clinical Trials Insight: 700020249

Phase of Trial: Phase II

Latest Information Update: 23 Apr 2008

At a glance

  • Drugs Ozarelix (Primary)
  • Indications Benign prostatic hyperplasia
  • Focus Therapeutic Use
  • Sponsors Spectrum Pharmaceuticals
  • Most Recent Events

    • 23 Apr 2008 Status change from in progress to completed, according to Spectrum Pharmaceuticals.
    • 22 Apr 2008 Results reported by Spectrum Pharmaceuticals, announced in an AEterna Zentaris media release.
    • 01 May 2007 Status change from initiated to in progress
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top